About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

European Physicians Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production

Citation:

European Cardiovascular Disease 2007;3(1):16–20

Expanded Lipid Testing Critical to Managing Coronary Artery Disease

Citation:

European Cardiovascular Disease 2007;3(2):24–6

Ezetimibe - An Overview of its Low-density Lipoprotein Cholesterol Lowering Efficacy

Citation:

European Cardiovascular Disease 2007;3(1):23–5

Fibrates — The Other Life-saving Lipid Drugs

Citation:

US Cardiology 2004;1(1):1–6